drugset / Trial / NCT03084809

Chemotherapy Combined With CIK Treating Colon Cancer

NCT03084809

Phase 4 Completed 46 enrolled China Meitan General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Cytokine-induced killer cells (CIK) is an auxiliary antitumor treatment. The investigators aim to evaluate the clinical efficacy of chemotherapy combined with CIK in the treatment of postoperative colorectal cancer patients. And to provide useful reference for the clinical application of CIK in colorectal cancer patients.

Timeline

Start
2012-05-06
Primary completion
2014-09-15
Completion
2014-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject CIK cells Cell therapy
Background Leucovorin Small molecule 200 mg/m2 Intravenous
Background Oxaliplatin Small molecule 130 mg/m2 Intravenous
Background fluorouracil Small molecule 500 mg/m2 Intravenous

Indications